Ionis Pharmaceuticals (IONS) PT Raised to $110 at Oppenheimer

April 29, 2026 5:40 PM

Oppenheimer analyst Jay Olson raised the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $110.00 (from $104.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found